George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: -0.50 (-2.78%)
Spread: 1.00 (5.882%)
Open: 17.50
High: 17.50
Low: 17.50
Prev. Close: 18.00
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Annual General Meeting

21 Sep 2023 11:12

RNS Number : 2343N
Thruvision Group PLC
21 September 2023
 

21 September 2023

Thruvision Group plc

 

Result of Annual General Meeting

 

Thruvision Group plc (AIM: THRU), the leading provider of walk-through security technology, announces that following the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed by the requisite majority. The number of proxies received in respect of each resolution were as follows:

 

Resolution

Total votes for

%

Total votes against

%

Total votes cast

Votes withheld

1.

Receipt of directors and auditors report

115,672,112

100.00

0

0.00

115,672,112

2,922

2.

Approval of remuneration report

115,595,721

99.94

69,972

0.06

115,665,693

9,341

3.

Re-election of Tom Black

115,667,442

100.00

4,670

0.00

115,672,112

2,922

4.

Re-election of Colin Evans

115,667,442

100.00

4,670

0.00

115,672,112

2,922

5.

Re-election of Richard Amos

115,662,442

100.00

4,670

0.00

115,667,112

7,922

6.

Re-election of Katrina Nurse

115,662,442

99.99

9,670

0.01

115,672,112

2,922

7.

Re-election of Victoria Balchin

115,662,442

99.99

9,670

0.01

115,672,112

2,922

8.

Re-appointment of Auditors

115,657,442

99.99

14,670

0.01

115,672,112

2,922

9.

Authority for Directors to set Auditors remuneration

115,667,442

100.00

4,670

0.00

115,672,112

2,922

10. 

Authority for Directors to allot equity securities

115,661,873

99.99

10,239

0.01

115,672,112

2,922

11. 

Authority for Directors to allot equity securities for cash on a non-premptive basis

115,639,873

99.97

32,239

0.03

115,672,112

2,922

12. 

Authority for Directors to allot equity securities for cash in respect of an acquisition or other capital project.

115,634,873

99.97

32,239

0.03

115,667,112

7,922

13. 

Authority for the Company to make market purchases of its own Ordinary Shares

115,645,112

99.98

22,000

0.02

115,667,112

7,922

14. 

Authority for the Directors to extend the life of the Thruvison Sharesave Scheme

115,666,023

100.00

4,670

0.00

115,670,693

4,341

 

 

Notes

1. Any proxy appointments which gave discretion to the Chairman have been included in the 'Total votes for' total.

2. A 'Vote Withheld' is not a valid vote in law and was not counted in the calculation of the proportion of the votes 'for' or 'Against' a resolution. 

3. All percentages have been rounded to two decimal places.

 

 

For further information please contact:

 

Thruvision Group plc

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer

+44 (0)1235 425400

Investec Investment Banking (NOMAD & Broker)

James Rudd / Patrick Robb / Sebastian Lawrence

+44 (0)20 7597 5970

 

Meare Consulting

Adrian Duffield

+44 (0) 7990 858548

 

About Thruvision (www.thruvision.com)

Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKDBKKBKDBCB
Date   Source Headline
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.